A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
Clinical trial NCT07122414 · RECRUITING
Trial details
- NCT number
- NCT07122414
- Sponsor
- Suzhou Forlong Biotechnology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-16
- Primary completion
- 2027-10-10
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.